Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Long-Term Deferred Tax: 2020-2023

  • Universe Pharmaceuticals' Long-Term Deferred Tax fell 55.55% to $599,078 in Q3 2023 from the same period last year, while for Sep 2023 it was $599,078, marking a year-over-year decrease of 55.55%. This contributed to the annual value of $599,078 for FY2023, which is 55.55% down from last year.
  • Per Universe Pharmaceuticals' latest filing, its Long-Term Deferred Tax stood at $599,078 for Q3 2023, which was down 27.84% from $830,259 recorded in Q1 2023.
  • In the past 5 years, Universe Pharmaceuticals' Long-Term Deferred Tax registered a high of $186.5 billion during Q3 2020, and its lowest value of $599,078 during Q3 2023.
  • In the last 3 years, Universe Pharmaceuticals' Long-Term Deferred Tax had a median value of $869,997 in 2021 and averaged $926,593.
  • In the last 5 years, Universe Pharmaceuticals' Long-Term Deferred Tax crashed by 100.00% in 2021 and then surged by 54.91% in 2022.
  • Over the past 4 years, Universe Pharmaceuticals' Long-Term Deferred Tax (Quarterly) stood at $186.5 billion in 2020, then slumped by 100.00% to $869,997 in 2021, then skyrocketed by 54.91% to $1.3 million in 2022, then crashed by 55.55% to $599,078 in 2023.
  • Its Long-Term Deferred Tax was $599,078 in Q3 2023, compared to $830,259 in Q1 2023 and $1.3 million in Q3 2022.